Pioneering the next generation of mental health treatments
We are on a mission to develop effective, rapid-acting and accessible medicines for people living with mental health conditions
Self Reflected by Greg Dunn
Reducing
the unmet
need in
mental
health
Nearly 1 billion people suffer from mental disorders around the world.
World Health Organisation, 2022
The global economic cost of mental health disorders is expected to reach $6 trillion by 2030.
The Lancet Global Health · Mental health matters, 2020
Most people living with a mental disorder do not have access to effective care.
World Health Organisation, 2022

We want to be a part of the solution. 


Leveraging
the potential of
next-generation
compounds

Studies have shown that our investigational psychedelic-based compounds

can be administered in a short clinic visit
are well-tolerated
can deliver rapid, robust, and lasting treatment effects
Supporting
the mental
health
treatment
ecosystem

We are proud to collaborate with stakeholders from across the mental health landscape to accelerate research into novel mental health treatments and to support clinical trial participants and patients in need.

More about
Partnerships
News
and
views
Read all news